| 1. |
Manzoor, Mehwish, Mehwish Solangi, Shahnaz Perveen, Uzma Salar, Fouzia Naz, Jamshed Iqbal, Zahid Hussain, Aqeel Imran, Muhammad Taha, and Khalid Mohammed Khan. (2024), "Exploring tricycle acridines as prospective urease inhibitors: synthesis via microwave assistance, in vitro evaluation, kinetic profiling, and molecular docking investigations", Iranian Journal of chemical society, pp: 1163-1183., Vol: 21, Issue: 4, Impact Factor: 2.2
(External URL)
|
| 2. |
Faiza Seraj, Khalid Mohammed Khan, Jamshed Iqbal, Aqeel Imran, Zahid Hussain, Uzma Salar, Shehryar Hameed & Muhammad Taha (2023), "Evaluation of synthetic aminoquinoline derivatives as urease inhibitors: in vitro, in silico and kinetic studies", Future Medicinal Chemistry, Impact Factor: 4.76
|
| 3. |
Rabia Basri, Shamool Fatima, Saquib Jalil, Aqeel Imran, Noor Fatima, Asad Syed, Ali H. Bahkali, Jamshed Iqbal, Zahid Shafiq (2023), "2-Oxoquinoline-based-thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors", Archiv der Pharmazie, Impact Factor: 5.1
|
| 4. |
Saira Naseem, Ahmed Temirak, Aqeel Imran, Saquib Jalil,Shamool Fatima, Parham Taslimi, Jamshed Iqbal, Mussarat Tasleem, Muhammad Nawaz Tahir f and Zahid Shafiq (2023), "Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease", RSC Advances , pp: 17526-17535, Vol: 13, Impact Factor: 4.036
|
| 5. |
Ayesha Naseer , Faisal Abdul rehman Osra , Asia Naz Awan,, Aqeel Imran , Abdul Hameed , Syed Adnan Ali Shah , Jamshed Iqbal and Zainul Amiruddin Zakaria (2022), "Exploring Novel Pyridine Carboxamide Derivatives As Urease Inhibitors: Synthesis, Molecular Docking, Kinetic Studies and ADME Profile", Pharmaceuticals , pp: 1288, Vol: 15, Issue: 10
(External URL)
|
| 6. |
Aqeel Imran, Muhammad Tariq Shehzad, Syed Jawad Ali Shah, Mark Laws, Taha al-Adhami, Khondaker Miraz Rahman, Imtiaz Ali Khan, Zahid Shafiq and Jamshed Iqbal. (2022), "Development, Molecular Docking, and In Silico ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications via Suppression of the Polyol Pathway", ACS Omega , pp: 26425–26436, DOI: https://doi.org/10.1021/acsomega.2c02326, Impact Factor: 4.13
|
| 7. |
Zahid Hussain, Abid Mahmood, Qasim Shah, Aqeel Imran, Ehsan Ullah Mughal, Wajiha Khan, Ayesha Baig, Jamshed Iqbal, and Amara Mumtaz (2022), "Synthesis and Evaluation of Amide and Thiourea Derivatives as Carbonic Anhydrase (CA) Inhibitors", ACS Omega, Impact Factor: 4.13
|
| 8. |
Syeda Uroos Qazi, Asia Naz, Aqeel Imran and Jamshed Iqbal . (2022), "Urease inhibitory kinetics, molecular docking, SAR and ADME studies of imine analogues.", New Journal of chemistry
|
| 9. |
Aqeel Imran , MuhammadTariq Shehzad,Taha al Adhami, Khondaker Miraz Rahman Mark Laws, Rima al daharty, ZahidShafiq, Jamshed Iqbal (2022), "Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study", Scientific Reports , pp: 5734, Vol: 12, DOI: https://doi.org/10.1038/s41598-022-09658-z, Impact Factor: 4.13
|
| 10. |
Laws, Mark; Surani, Yasmin M.; Hasan, Md. M.; Chen, Yiyuan; Jin, Peiqin; Al-Adhami, Taha; Chowdhury, Madiha; Imran, Aqeel; Psaltis, Ioannis; Jamshidi, Shirin; Nahar, Kazi S.; Rahman, Khondaker Miraz (2021), "Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19", Current Medicinal Chemistry, Impact Factor: 4.1
|
| 11. |
Aqeel Imran MuhammadTariq Shehzad, Taha al Adhami, Khondaker Miraz Rahman, Dilawar Hussain, Zahid Shafiq, Jamshed Iqbal (2021), "Development of Coumarin-Thiosemicarbazone Hybrids as Aldose Reductase Inhibitors: Biological Assays, Molecular docking, Simulation studies and ADME Evaluation.", Bioorganic chemistry , pp: 105164, Vol: 115, DOI: https://doi.org/10.1016/j.bioorg.2021.105164, Impact Factor: 5.3
|
| 12. |
Mohsinul Mulk Bacha, Humaira Nadeem1 , Sumera Zaib, Sadia Sarwar, Aqeel Imran, Shafiq Ur Rahman,Hafiz Saqib Ali, Muazzam Arif and Jamshed Iqbal (2021), "Rhodanine-3-acetamide derivatives as aldose and aldehyde reductase inhibitors to treat diabetic complications: synthesis, biological evaluation, molecular docking and simulation studies", BMC Chemistry
|
| 13. |
Muhammad Tariq Shehzad, Aqeel Imran, Abdul Hameed, Mariya al Rashida, Marium Bibi,d Maliha Uroos,e Asnuzilawati Asari Shafia Iftikhar,Habsah Mohamad,h Muhammad Nawaz Tahir,i Zahid Shafiq and Jamshed Iqbal (2021), ""Exploring Synthetic and Therapeutic Prospects of New Thiazoline Derivatives as Aldose Reductase (ALR2) Inhibitors" ", RSC Advances
|
| 14. |
Muhammad Tariq Shehzad, Ajmal Khan , Sobia Ahsan Halim, Abdul Hameed, Aqeel Imran, Jamshed Iqbal, Aziz Ullah, Asnuzilawati Asari, Samra Khan, Zahid Shafiq & Ahmed Al-Harrasi (2021), "synthesis of indole substituted thiosemicarbazones as an aldose reductase inhibitor: an in vitro, selectivity and in silico study", Future Medicinal chemistry , Impact Factor: 3.4
|
| 15. |
Javid, N., Munir, R., Chaudhry, F., Imran, A., Zaib, S., Muzaffar, A., & Iqbal, J. (2020), "Exploiting oxadiazole-sulfonamide hybrids as new structural leads to combat diabetic complications via aldose reductase inhibition. ", Bioorganic chemistry, Impact Factor: 5.27
|
| 16. |
Hamad Asad, Mohsin Abbas Khan, Irshad Ahmad, Aqeel Imran, Ruqaiya Khalil, Taha Al-Adhami, Khondaker Miraz Rahman, Nudrat Zahra, and Zahid Shafiq. "Probing sulphamethazine and sulphamethoxazole based Schiff bases as urease inhibitors; synthesis, chara (2020), "Probing sulphamethazine and sulphamethoxazole based Schiff bases as urease inhibitors; synthesis, characterization, molecular docking and ADME evaluation." ", Bioorganic chemistry, Impact Factor: 5.27
|
| 17. |
Shehzad, M. T., Imran, A., Njateng, G. S. S., Hameed, A., Islam, M., Al-Rashida, M., ... & Iqbal, J. (2019), "Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study.", Bioorganic Chemistry , Impact Factor: 5.27
|
| 18. |
Muhammad Tariq Shehzad, Abdul Hameed, Mariya al-Rashida, Aqeel Imran, Maliha Uroos,Asnuzilawati Asari, Habsah Mohamad, Muhammad Islam, Shafia Iftikhar, Zahid Shafiq,Jamshed Iqbal (2019), "Exploring antidiabetic potential of adamantyl-thiosemicarbazones via aldose reductase (ALR2) inhibition ", Bioorganic chemistry, Impact Factor: 5.27
|
| 19. |
Saeed, Aamer, Aqeel Imran, Pervaiz A. Channar, Mohammad Shahid, Wajahat Mahmood, and Jamshed Iqbal (2015), "2-(Hetero (aryl) methylene) hydrazine-1-carbothioamides as Potent Urease Inhibitors.", Chemical Biology & Drug Design, Impact Factor: 2.57
|